Case Study
Global specialty pharma deploys OCE Remote Engagement in two weeks for immediate increase in HCP details
Jun 17, 2021
Download

A global specialty pharmaceutical company based in the United Kingdom had ambitious growth plans to institute a comprehensive omni-channel sales strategy, but the unanticipated limitation of physical access from COVID-19 was preventing reps from connecting with their customers. As an emerging pharma company, they had incurred an initially steep drop off in HCP details after global restrictions were mandated. The customer needed to quickly address these constraints so their commercial teams could resume engagements through a new remote channel.

Related solutions

Contact Us